Related references
Note: Only part of the references are listed.Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas
Natalia Bednarz-Knoll et al.
BRITISH JOURNAL OF CANCER (2022)
Platelet infiltration predicts survival in postsurgical colorectal cancer patients
Yiming Miao et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
The Gene Ontology resource: enriching a GOld mine
Seth Carbon et al.
NUCLEIC ACIDS RESEARCH (2021)
Combined Assessment of the Tumor-Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
Cor J. Ravensbergen et al.
CELLS (2021)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
Nuttavut Sumransub et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer
Sophie C. Hagenaars et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery
Liju Zong et al.
GYNECOLOGIC ONCOLOGY (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Lei Zhang et al.
CELL (2020)
Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer
Bruna Pellini et al.
THORACIC SURGERY CLINICS (2020)
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
Myriam Chalabi et al.
NATURE MEDICINE (2020)
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura et al.
NATURE MEDICINE (2020)
Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer
Stephanie M. Zunder et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer
Ke Zhao et al.
EBIOMEDICINE (2020)
The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
G. W. van Pelt et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
How liquid biopsies can change clinical practice in oncology
G. Siravegna et al.
ANNALS OF ONCOLOGY (2019)
Prognostic significance of tumor budding, tumor-stroma ratio, cell nests size, and stroma type in laryngeal and pharyngeal squamous cell carcinomas
Georgia Karpathiou et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications
B. Soldevilla et al.
EUROPEAN JOURNAL OF CANCER (2019)
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2019)
Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
Marloes Smit et al.
JMIR RESEARCH PROTOCOLS (2019)
Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring
Myron G. Best et al.
CANCER RESEARCH (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding et al.
CELL (2018)
The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact
Gabi W. van Pelt et al.
HISTOPATHOLOGY (2018)
The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients
Kiki M. H. Vangangelt et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial
Anouck Huijbers et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
G. W. van Pelt et al.
VIRCHOWS ARCHIV (2018)
Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis
Jiang Jian et al.
ONCOTARGET (2017)
Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients
Paolo Aurello et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2017)
Liquid Biopsy: Current Status and Future Perspectives
Sonja Mader et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Prognostic significance of the tumor-stroma ratio in gallbladder cancer
H. Li et al.
NEOPLASMA (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
Guohe Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Feifei Cheng et al.
ONCOTARGET (2016)
PF4 Promotes Platelet Production and Lung Cancer Growth
Ferdinando Pucci et al.
CELL REPORTS (2016)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients
Hei Jason Chan et al.
ONCOTARGET (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Beifang Niu et al.
BIOINFORMATICS (2014)
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
A. Huijbers et al.
ANNALS OF ONCOLOGY (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Cancer gene expression signatures - The rise and fall?
Frederic Chibon
EUROPEAN JOURNAL OF CANCER (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Interrater reliability: the kappa statistic
Mary L. McHugh
BIOCHEMIA MEDICA (2012)
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
J. Joshua Smith et al.
GASTROENTEROLOGY (2010)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)